Veterinary Pain Management Market Size, Share and Analysis by Product Type (Drugs, Devices), By Application (Joint Pain, Post-Operative Pain, Cancer Pain), By Animal (Companion, Livestock), By Distribution Channel (Veterinary Hospitals, Pet Clinics) and Geography Forecast, 2026-2034

The global veterinary pain management market size was valued at USD 2.8 billion in 2025. The market is projected to grow from USD 2.99 billion in 2026 to USD 5.11 billion by 2034, exhibiting a CAGR of 6.92% during the forecast period.

Veterinary pain management is concerned with and refers to a medical approach towards a range of symptoms of pain exhibited by the animal and to provide treatment for these symptoms. Veterinary pain is often a response to actual or potential tissue damage, it has a protective role. Veterinary pain can be classified according to four types: acute, chronic, cancer and neuropathic. The recognition of common signs of veterinary pain such as physical symptoms like change in heart rate, heavy breathing, enlarged pupil and slowed reflexes and behavioral symptoms like reduced appetite, reluctance to lie down, unusual restlessness or anxiety, withdrawn behavior, mood or personality changes, licking, biting, or rubbing the site of pain and irritability play a central role.

The causes of veterinary pain include cancers, trauma, arthritis, bloating and gastric torsion, diabetes mellitus, obesity, and seizures. Veterinary pain management incorporates treatments such as drugs, devices, round-the-clock monitoring, reduction in stressors and diet management. Due to greater awareness regarding animal healthcare, there is a greater focus on the development of newer veterinary pain management therapeutics. According to Animal Cancer Foundation, there are 65 million dogs and 35 million cats in the U.S., out of which every year, there are 6 million new diagnoses of cancer in dogs and similarly in cats too. According to a research study, it was estimated that appendicular osteoarthritis affects 200,000 dogs in the U.K. annually. These trends are resulting in the considerable growth of the veterinary pain management market. 

To gain extensive insights into the market, Download for Customization

One of the key drivers of the growth in veterinary pain management is the increasing trend of animal ownership and greater awareness among individuals regarding animal healthcare. These have led to greater visits to the veterinary practices were due to the greater diagnosis of animal diseases, there are increasing numbers of animals, who are administered pain management therapeutics. Also, due to the greater prevalence of animal diseases which also includes epizootic diseases, there is a greater awareness and rising need of veterinary pain management therapeutics. 

The factor that is expected to inhibit the growth of the market is the increasing animal healthcare costs associated with veterinary pain management products. For instance, in the emerging markets where there is an absence of animal insurance, the costs of certain veterinary pain management products are too high for the individuals to bear. 

Key Players Covered 

Some of the major companies that are present in the global Veterinary Pain Management market are Boehringer Ingelheim International GmbH, Ceva, Zoetis, Vetoquinol S.A., Elanco, Intervet Inc., and Bayer AG and other players.

SEGMENTATION

At present, drugs account for the largest proportion of the market and this is not expected to change in the forecast period because veterinary pain management drugs are more widely used and are cheaper in terms of cost. Drugs are able to treat a wide variety of diseases, are more easily available, and also they are convenient to administer in certain scenarios compared to devices. 

Key Insights 

• Pipeline analysis
• The regulatory scenario for key countries
• Overview of non-conventional pain management methods
• Key industry developments
• Opportunity assessment of untapped emerging markets 

Regional Analysis: 

The global Veterinary Pain Management market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America followed by Europe are the two largest markets for Veterinary Pain Management at present and they are expected to account for a large proportion of the market in the forecast period as well. North America holds the largest market share due to the high ownership of pet animals, the presence of animal insurance and the high expenditure on animal healthcare. In the Asia Pacific region, China and Japan are expected to be the fastest emerging markets due to the presence of a large population of livestock animals and also the increasing awareness regarding animal healthcare, strongly driven by government initiatives. 

Key Industry Developments

• In July 2018, CannPal Animal Therapeutics Ltd announced a partnership with Eurofins Animal Health Pty Ltd for the development of cannabis-derived pain treatment for the felines
• In April 2018, Henry Schein announced a plan intending to merge the animal health business with the Vets First Choice for the creation of an innovative approach for the animal healthcare
• In January 2017, Elanco announced the availability of Galliprant (grapiprant tablets) for the treatment of canine osteoarthritis, which also relieved the pain and inflammation of the animals.